Evidence map›Paper›PMID 36721516›Full record

ArticleIranian journal of microbiology2022

First report of SPM metallo-β-lactamases producing

Abdelhamid Massik, Lahbib Hibaoui, Benboubker Moussa, Ghita Yahyaoui, Bouchra Oumokhtar, Mustapha Mahmoud

Open access · diamondAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Iranian journal of microbiology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.2field-weighted citation impact, top 60% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 3 citations in OpenAlex.

  1. Carbapenem-ResistantMicroorganisms · 2025
    Review
  2. Carbapenem Resistance inMicroorganisms · 2025
    Review
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Abdelhamid MassikLaboratory of Microbiology and Molecular Biology, CHU Hassan II, Fez, Morocco.
Lahbib HibaouiLaboratory of Microbiology and Molecular Biology, CHU Hassan II, Fez, Morocco.
Benboubker MoussaHuman Pathologies, Biomedicine and Environment Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Ghita YahyaouiLaboratory of Microbiology and Molecular Biology, CHU Hassan II, Fez, Morocco.
Bouchra OumokhtarHuman Pathologies, Biomedicine and Environment Laboratory, Faculty of Medicine and Pharmacy, Sidi Mohammed Ben Abdellah University, Fez, Morocco.
Mustapha MahmoudLaboratory of Microbiology and Molecular Biology, CHU Hassan II, Fez, Morocco.
Centre Hospitalier Universitaire Hassan II · MASidi Mohamed Ben Abdellah University · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background and Objectives: Carbapenem-resistant Materials and Methods: Seventy carbapenem-resistant Results: Carbapenemase genes were detected in our isolates: the OXA-51 gene and the ISbA1 sequence were detected in all isolates (100%), the OXA-23 and OXA-58 genes were detected in 82.85% and 10% of isolates respectively, MBL genes were dominated by VIM 39 isolates (55.7%), followed by GIM 26 isolates (37%), SIM 20 isolates (28.5%), IMP 8 isolates (11, 4%), NDM 3 isolates (4%) and for the first time in Morocco SPM with 4 isolates (5.7%). Conclusion: The emergence of resistance of

Indexed as

Acinetobacter baumanniiCarbapenemsMetallo-beta-lactamaseResistance

Identifiers

PMID36721516
PMCPMC9867632
OpenAlexW4291926327

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.